The lymphocyte count-to-CRP ratio (LCR) has been associated with symptom severity in patients with coronavirus disease 2019 [10] and exhibits predictive value for various clinical conditions, including cancer and myocardial infarction [11,12]. This evidence concerns the gene CRP and cancer.